Related Experiment Video
Updated: May 27, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
Sarcopenic obesity: strategies for management
Melissa J Benton1, Maria D Whyte, Brenda W Dyal
1Valdosta State University College of Nursing, Valdosta, GA, USA. mjbenton@valdosta.edu
The American Journal of Nursing
|November 16, 2011
Summary
Sarcopenia and sarcopenic obesity are age-related conditions involving muscle loss and increased body fat. Diet and exercise, particularly resistance training and protein intake, are key to prevention and management in older adults.
Area of Science:
- Gerontology
- Nutritional Science
- Exercise Physiology
Background:
- Sarcopenia, the age-related loss of muscle mass, is a significant health concern.
- Sarcopenic obesity combines muscle loss with increased body fat, leading to reduced strength, function, and quality of life.
- These conditions are associated with increased mortality risk.
Purpose of the Study:
- To describe the clinical significance of sarcopenia and sarcopenic obesity.
- To outline the pathophysiology of these age-related conditions.
- To present management strategies for healthy older adults.
Main Methods:
- Review of current literature on sarcopenia and sarcopenic obesity.
- Discussion of dietary interventions, including protein supplementation and high-protein diets.
- Emphasis on exercise strategies, particularly resistance training.
Main Results:
- Diet and exercise are crucial for preventing and reversing muscle loss and fat gain.
- Resistance training is vital for maintaining muscle mass and maximizing energy expenditure.
- Adequate dietary protein intake supports muscle health.
Conclusions:
- Nurses play a key role in educating older patients about sarcopenia and sarcopenic obesity.
- Promoting resistance training and dietary protein can prevent or reverse these conditions.
- Management strategies are essential for improving health outcomes in aging populations.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...